PL2525789T3 - Farmaceutyczne formulacje naproksenu do kapsułkowania w miękkich kapsułkach żelowych i ich kombinacje - Google Patents

Farmaceutyczne formulacje naproksenu do kapsułkowania w miękkich kapsułkach żelowych i ich kombinacje

Info

Publication number
PL2525789T3
PL2525789T3 PL11734283T PL11734283T PL2525789T3 PL 2525789 T3 PL2525789 T3 PL 2525789T3 PL 11734283 T PL11734283 T PL 11734283T PL 11734283 T PL11734283 T PL 11734283T PL 2525789 T3 PL2525789 T3 PL 2525789T3
Authority
PL
Poland
Prior art keywords
naproxen
combinations
pharmaceutical formulations
soft gel
gel encapsulation
Prior art date
Application number
PL11734283T
Other languages
English (en)
Inventor
John Lopez
Peter Draper
Sankalp Vashishtha
Nancy Klassen
Christina Armstrong
Original Assignee
Catalent Ontario Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Ontario Limited filed Critical Catalent Ontario Limited
Publication of PL2525789T3 publication Critical patent/PL2525789T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833Encapsulating processes; Filling of capsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11734283T 2010-01-19 2011-01-19 Farmaceutyczne formulacje naproksenu do kapsułkowania w miękkich kapsułkach żelowych i ich kombinacje PL2525789T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2690488A CA2690488C (en) 2010-01-19 2010-01-19 Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
PCT/CA2011/000059 WO2011088553A1 (en) 2010-01-19 2011-01-19 Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
EP11734283.2A EP2525789B1 (en) 2010-01-19 2011-01-19 Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof

Publications (1)

Publication Number Publication Date
PL2525789T3 true PL2525789T3 (pl) 2022-01-03

Family

ID=44303618

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11734283T PL2525789T3 (pl) 2010-01-19 2011-01-19 Farmaceutyczne formulacje naproksenu do kapsułkowania w miękkich kapsułkach żelowych i ich kombinacje

Country Status (13)

Country Link
US (4) US9480667B2 (pl)
EP (2) EP3909567A1 (pl)
JP (2) JP5975884B2 (pl)
AU (1) AU2011207061B2 (pl)
CA (1) CA2690488C (pl)
DK (1) DK2525789T3 (pl)
ES (1) ES2880813T3 (pl)
HU (1) HUE055771T2 (pl)
MX (1) MX358636B (pl)
PL (1) PL2525789T3 (pl)
PT (1) PT2525789T (pl)
SI (1) SI2525789T1 (pl)
WO (1) WO2011088553A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201301626D0 (en) 2013-01-30 2013-03-13 Dignity Sciences Ltd Composition comprising 15-OHEPA and methods of using the same
EP3151825B1 (en) * 2014-06-04 2020-03-25 DS Biopharma Limited Pharmaceutical compositions comprising dgla and use of same
CN104083339A (zh) * 2014-08-04 2014-10-08 人福普克药业(武汉)有限公司 萘普生钠软胶囊及其制备方法
US10368284B2 (en) * 2014-11-12 2019-07-30 T-Mobile Usa, Inc. Quality of experience-based handover management
WO2016181221A1 (en) 2015-05-13 2016-11-17 Dignity Sciences Limited Compositions comprising 15-oxo-epa or 15-oxo-dgla and methods of making and using same
US20170020836A1 (en) 2015-07-21 2017-01-26 Dignity Sciences Limited Compositions Comprising 15-HEPE and Methods of Treating or Preventing Cancer and Neurologic Disease
WO2019222100A1 (en) 2018-05-16 2019-11-21 Zumeta Perez Javier High concentration suspension formulation for cold and flu soft gel capsule medications
CN109692127A (zh) * 2019-03-15 2019-04-30 王征 一种密封小胶囊的制备方法
CN113950324A (zh) * 2019-04-26 2022-01-18 R.P.谢勒技术有限公司 微型软胶囊萘普生组合物
US20220233452A1 (en) * 2021-01-25 2022-07-28 R.P. Scherer Technologies, Llc Mini softgel naproxen composition

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
AU7604094A (en) 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
PL315635A1 (en) * 1994-01-24 1996-11-25 Procter & Gamble Method of solubilising hardly pharmaceutically active substances
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives
US5641512A (en) 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
ATE429210T1 (de) * 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen
US6383515B2 (en) * 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US6387400B1 (en) 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
US20090318558A1 (en) * 2003-02-12 2009-12-24 Jae-Hwan Kim Solvent system of hardly soluble drug with improved dissolution rate
JP2006514119A (ja) * 2003-02-12 2006-04-27 アール アンド ピー コリア カンパニー リミテッド 溶解率が向上した難溶性薬剤の溶媒系
US20070053868A1 (en) * 2005-03-08 2007-03-08 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents
US7582679B2 (en) 2006-02-03 2009-09-01 Pharmaceutics International Incorporated Compositions containing solid ibuprofen concentrates and methods of making solid ibuprofen concentrates
US20080014274A1 (en) * 2006-07-14 2008-01-17 Wyeth Enhanced stability phenylephrine liquid compositions
US20110052679A1 (en) 2009-08-25 2011-03-03 Pharmaceutics International, Inc. Solid naproxen concentrates and related dosage forms

Also Published As

Publication number Publication date
PT2525789T (pt) 2021-07-19
WO2011088553A1 (en) 2011-07-28
US20200046662A1 (en) 2020-02-13
EP2525789A1 (en) 2012-11-28
JP2016094462A (ja) 2016-05-26
EP3909567A1 (en) 2021-11-17
JP2013517304A (ja) 2013-05-16
MX2012008300A (es) 2012-11-23
US20240139132A1 (en) 2024-05-02
US20130011470A1 (en) 2013-01-10
US9480667B2 (en) 2016-11-01
US11896566B2 (en) 2024-02-13
ES2880813T3 (es) 2021-11-25
HUE055771T2 (hu) 2021-12-28
US10463637B2 (en) 2019-11-05
CA2690488A1 (en) 2011-07-19
DK2525789T3 (da) 2021-07-19
CA2690488C (en) 2013-06-11
SI2525789T1 (sl) 2021-12-31
EP2525789A4 (en) 2014-04-30
AU2011207061B2 (en) 2015-05-28
AU2011207061A1 (en) 2012-07-26
MX358636B (es) 2018-08-29
US20170020832A1 (en) 2017-01-26
JP5975884B2 (ja) 2016-08-23
EP2525789B1 (en) 2021-06-02

Similar Documents

Publication Publication Date Title
IL253870B (en) Certain amino-pyrimidines and pharmaceutical preparations containing them
PL2525789T3 (pl) Farmaceutyczne formulacje naproksenu do kapsułkowania w miękkich kapsułkach żelowych i ich kombinacje
HK1183802A1 (en) Therapeutic oral composition
HK1175947A1 (en) Pharmaceutical compositions and methods of making same
PL3178472T3 (pl) Doustne preparaty metylonaltreksonu
PL2625245T3 (pl) Fluoryzujące żelowe formulacje oraz ich zastosowania
GB201104473D0 (en) Improved pharmaceutical compositions and methods of delivery
GB201302653D0 (en) Pharmaceutical compositions and methods of treatment
SI2605757T1 (sl) Formulacije na osnovi nalbufina in njihove uporabe
HK1183228A1 (zh) 口服藥物治療方法和組合物
PL2557943T3 (pl) Doustne weterynaryjne kompozycje farmaceutyczne i nutraceutyki
LT2525827T (lt) Loratadino farmacinės kompozicijos, skirtos kapsuliavimui ir jų kombinacijos
EP2714024A4 (en) ORAL FORMULATIONS FROM ANTIOXIDANTS FACED ON MITOCHONDRIA AND THE PREPARATION AND USE THEREOF
EP2552210A4 (en) FORMULAS FROM MAZINDOL
IL224191A (en) Compositions of vitamin d and cmc epi-14 analogues
EP2780029A4 (en) ORAL LEPTIN FORMULATIONS AND USES THEREOF
EP2419085A4 (en) IMPROVED DEVICES FOR ORAL MEDICINAL PRODUCTS AND MEDICINAL PRODUCTS
EP2531180A4 (en) ORAL COMPLEX COMPOSITION WITH PSEUDOEPHEDRINE AND LEVOCETIRIZIN
EP2529755A4 (en) PHARMACEUTICAL COMPOSITION AND PREPARATION THEREFOR FOR ORAL ADMINISTRATION
PL390701A1 (pl) Naturalny preparat farmaceutyczno-kosmetyczny
GB201012046D0 (en) Pharmaceutical formulations
GB201012047D0 (en) Pharmaceutical formulations
AU2010901846A0 (en) Therapeutic methods and compositions
EP2657236A4 (en) NEW 2-ALKYNYL-N9-PROPARGYLADENINE AND ITS MEDICAL USE
GB201003741D0 (en) Methods and therapeutic compositions